Dysglycaemia in CF - Why are investigating it, what should we measure and how should we treat it?

Affiliations

¹ Manchester Adult Cystic Fibrosis Centre, Manchester Foundation Trust, UK. Electronic address: amanda.brennan@mft.nhs.uk.
² Manchester Adult Cystic Fibrosis Centre, Manchester Foundation Trust, UK.

Free article

Editorial

Amanda Brennan et al. J Cyst Fibros. 2018 Nov.

Free article

. 2018 Nov;17(6):690-691.

doi: 10.1016/j.jcf.2018.09.005. Epub 2018 Oct 6.

¹ Manchester Adult Cystic Fibrosis Centre, Manchester Foundation Trust, UK. Electronic address: amanda.brennan@mft.nhs.uk.
² Manchester Adult Cystic Fibrosis Centre, Manchester Foundation Trust, UK.

No abstract available

Comment on

Quantifying fluctuation in glucose levels to identify early changes in glucose homeostasis in cystic fibrosis.
Brugha R, Wright M, Nolan S, Bridges N, Carr SB. Brugha R, et al. J Cyst Fibros. 2018 Nov;17(6):791-797. doi: 10.1016/j.jcf.2017.12.004. Epub 2018 Jan 10. J Cyst Fibros. 2018. PMID: 29329721
Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline.
Chan CL, Vigers T, Pyle L, Zeitler PS, Sagel SD, Nadeau KJ. Chan CL, et al. J Cyst Fibros. 2018 Nov;17(6):783-790. doi: 10.1016/j.jcf.2018.03.008. Epub 2018 Mar 23. J Cyst Fibros. 2018. PMID: 29580828 Free PMC article.
Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes.
Frost F, Dyce P, Nazareth D, Malone V, Walshaw MJ. Frost F, et al. J Cyst Fibros. 2018 Nov;17(6):798-803. doi: 10.1016/j.jcf.2018.05.005. Epub 2018 Jun 7. J Cyst Fibros. 2018. PMID: 29885744